Validation of a New Methodology for Mapping the Human Blood-Retinal Barrier Function

To validate a new methodology, named Retinal Leakage Analysis (RLA), for mapping the human Blood-Retinal Barrier (BRB) function, in the clinical practice.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age-Related Maculopathy Diabetic Macular Edema Eye Diseases Macular Degeneration Retinal Degeneration Retinal Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

AIBILI Clinical Trial Center

Coimbra, Coimbra District, 3000-548, Portugal

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients diagnosed with AMD, or
Patients diagnosed with DME
Age over 18 years
Inform consent

Exclusion criteria

Cataract or other eye disease that may interfere with fundus examinations
Glaucoma
Dilatation of the pupil < 5 mm

Treatment and study plan

Primary outcomes

Blood-Retinal Barrier (BRB) function measured by Retinal Leakage Analysis (RLA).

Sponsors and collaborators

Lead sponsor

Association for Innovation and Biomedical Research on Light and Image

Other

Registry information

Important dates

Study start: 2008
Primary completion: 2010
Study completion: 2010
First posted: Sep 25, 2008
Registry last updated: Oct 15, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed